First in Human Dose Escalation Study of AU409 in Patients With Advanced Primary Liver Cancers or Advanced Solid Tumor With Liver Predominant Metastatic Disease
Latest Information Update: 11 Apr 2023
At a glance
- Drugs AU-409 (Primary)
- Indications Carcinoma; Cholangiocarcinoma; Liver cancer; Solid tumours
- Focus Adverse reactions; First in man
- 16 Mar 2023 Status changed from planning to recruiting.
- 05 Oct 2020 New trial record